Regulation of Schwann cell enshealthment and myelination by type III Neuregulin 1

III 型神经调节蛋白 1 对雪旺细胞健康和髓鞘形成的调节

基本信息

  • 批准号:
    8675621
  • 负责人:
  • 金额:
    $ 35.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-11 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

The long term goal of this research program is to elucidate how axons drive Schwann cell ensheathment and myelination. We are investigating the role of neuregulin-1 (NRG1), a neuronal growth factor which regulates the entire Schwann cell lineage, including the binary choice between ensheathment and myelination in the PNS. The mechanisms by which type III NRG1 drives Schwann cell ensheathment and myelination remain poorly understood. NRG1 binds to erbB receptors on Schwann cells, activating the PI 3-kinase, PLC-3, and MAP kinase signaling pathways. Our general model is that Schwann cell survival, ensheathment and myelin wrapping all require NRG1-dependent activation of PI 3-kinase whereas other signaling pathways may drive the sequential expression of myelin-specific transcription factors (TFs). Using a recently generated transgenic mouse that expresses an activated, membrane targeted form of Akt1, we will investigate further how NRG1 drives axon ensheathment, myelination, and survival. Specifically, we will: i) investigate whether Akt is a primary effector of PI 3-kinase- dependent survival and ensheathment by analyzing mice deficient in Akt isoforms and by expressing activated Akt in Schwann cells interacting with NRG1 deficient neurons, ii) characterize the role(s) of the TORC1 and TORC2 pathways in ensheathment and myelination, and iii) analyze whether Akt cooperates with other signals, including NFAT, during myelination, by crossing transgenic mice expressing activated Akt and NFAT transgenes and examine potential cooperative effects on myelination. These studies should provide important insights into how type III NRG1 on the axon drives survival, ensheathment and myelination by Schwann cells. Relevance: These studies seek to identify signals that promote myelin sheath formation, the cellular insulation that surrounds nerve fibers and is critical for their proper function and long term integrity. Findings in this study may therefore have important implications for the pathogenesis of disorders of myelinated fibers, including neuropathies, and lead to new therapeutic strategies to promote their repair.
这项研究计划的长期目标是阐明轴突如何驱动许旺细胞鞘和髓鞘形成。我们正在研究神经调节蛋白-1(NRG 1)的作用,NRG 1是一种调节整个雪旺细胞谱系的神经元生长因子,包括PNS中鞘化和髓鞘形成之间的二元选择。III型NRG 1驱动雪旺细胞鞘化和髓鞘形成的机制仍然知之甚少。NRG 1与雪旺细胞上的erbB受体结合,激活PI 3-激酶、PLC-3和MAP激酶信号通路。我们的一般模型是,雪旺细胞的生存,ensheathment和髓鞘包裹都需要NRG 1依赖性激活PI 3-激酶,而其他信号通路可能会驱动髓鞘特异性转录因子(TF)的顺序表达。使用最近产生的转基因小鼠,表达激活,膜靶向形式的Akt 1,我们将进一步研究NRG 1如何驱动轴突鞘,髓鞘形成和生存。具体而言,我们将:i)通过分析Akt同种型缺陷的小鼠和通过在与NRG 1缺陷的神经元相互作用的施万细胞中表达活化的Akt来研究Akt是否是PI 3-激酶依赖性存活和鞘化的主要效应物,ii)表征T0 RC 1和T0 RC 2途径在鞘化和髓鞘形成中的作用,和iii)分析Akt在髓鞘形成期间是否与其它信号(包括NFAT)合作,通过交叉表达激活的Akt和NFAT转基因的转基因小鼠,并检查对髓鞘形成的潜在协同作用。这些研究应该为轴突上的III型NRG 1如何驱动施万细胞的存活、鞘化和髓鞘形成提供重要的见解。相关性:这些研究试图确定促进髓鞘形成的信号,髓鞘是包围神经纤维的细胞绝缘,对它们的正常功能和长期完整性至关重要。因此,这项研究的发现可能对有髓纤维疾病(包括神经病)的发病机制具有重要意义,并导致新的治疗策略以促进其修复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES SALZER其他文献

JAMES SALZER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES SALZER', 18)}}的其他基金

Impact of Schwann Cell Pathology on Axon Structure and Function
雪旺细胞病理学对轴突结构和功能的影响
  • 批准号:
    10568051
  • 财政年份:
    2022
  • 资助金额:
    $ 35.65万
  • 项目类别:
Role and Regulation of Neural Stem Cells in Remyelination
神经干细胞在髓鞘再生中的作用和调节
  • 批准号:
    10412936
  • 财政年份:
    2018
  • 资助金额:
    $ 35.65万
  • 项目类别:
Role and Regulation of Neural Stem Cells in Remyelination
神经干细胞在髓鞘再生中的作用和调节
  • 批准号:
    10155591
  • 财政年份:
    2018
  • 资助金额:
    $ 35.65万
  • 项目类别:
Mechanisms of Node of Ranvier Assembly
Ranvier组装节点机制
  • 批准号:
    8675608
  • 财政年份:
    2013
  • 资助金额:
    $ 35.65万
  • 项目类别:
2012 Myelin Gordon Research Conference & Gordon Research Seminar
2012年髓磷脂戈登研究会议
  • 批准号:
    8317793
  • 财政年份:
    2012
  • 资助金额:
    $ 35.65万
  • 项目类别:
Assembly of the Node of Ranvier
朗飞节点集会
  • 批准号:
    7263674
  • 财政年份:
    2002
  • 资助金额:
    $ 35.65万
  • 项目类别:
Assembly of the Node of Ranvier
朗飞节点集会
  • 批准号:
    8049575
  • 财政年份:
    2002
  • 资助金额:
    $ 35.65万
  • 项目类别:
Mechanisms of Node of Ranvier Assembly
Ranvier组装节点的机制
  • 批准号:
    10212457
  • 财政年份:
    2002
  • 资助金额:
    $ 35.65万
  • 项目类别:
Assembly of the Node of Ranvier
朗飞节点集会
  • 批准号:
    7586695
  • 财政年份:
    2002
  • 资助金额:
    $ 35.65万
  • 项目类别:
Assembly of the Node of Ranvier
朗飞节点集会
  • 批准号:
    7363673
  • 财政年份:
    2002
  • 资助金额:
    $ 35.65万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.65万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了